Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gallamini

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
The Journal of Antimicrobial Chemotherapy|October 21, 2009
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patientsC Viscoli, R Herbrecht, H Akan, et al.
Haematologica|March 20, 2001
Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphomaG Santini, S Nati, M Spriano, et al.
Haematologica|January 1, 1994
Probability of cure in elderly Hodgkin's disease patientsA Levis, L Depaoli, A Urgesi, et al.
Haematologica|September 1, 1996
Results of a low aggressivity chemotherapy regimen (CVP/CEB) in elderly Hodgkin's disease patientsA Levis, L Depaoli, M Bertini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2013
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphomaM Dreyling, C Thieblemont, A Gallamini, et al.
Leukemia|March 26, 2014
Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphomaP Corradini, U Vitolo, A Rambaldi, et al.
Haematologica|May 1, 1997
Idarubicin in patients with diffuse large cell lymphomas: a randomized trial comparing VACOP-B (A = doxorubicin) vs VICOP-B (I = idarubicin)M Bertini, R Freilone, B Botto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
Combined modality treatment with a weekly brief chemotherapy (ACOP-B) followed by locoregional radiotherapy in localized-stage intermediate- to high-grade non-Hodgkin's lymphomaR Freilone, B Botto, U Vitolo, et al.
Leukemia|February 16, 2007
Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patientsI Ricca, A Rocci, D Drandi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2006
NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective surveyL Pagano, A Gallamini, G Trapè, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
The Journal of Antimicrobial Chemotherapy|October 21, 2009
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patientsC Viscoli, R Herbrecht, H Akan, et al.
Haematologica|March 20, 2001
Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphomaG Santini, S Nati, M Spriano, et al.
Haematologica|January 1, 1994
Probability of cure in elderly Hodgkin's disease patientsA Levis, L Depaoli, A Urgesi, et al.
Haematologica|September 1, 1996
Results of a low aggressivity chemotherapy regimen (CVP/CEB) in elderly Hodgkin's disease patientsA Levis, L Depaoli, M Bertini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2013
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphomaM Dreyling, C Thieblemont, A Gallamini, et al.
Leukemia|March 26, 2014
Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphomaP Corradini, U Vitolo, A Rambaldi, et al.
Haematologica|May 1, 1997
Idarubicin in patients with diffuse large cell lymphomas: a randomized trial comparing VACOP-B (A = doxorubicin) vs VICOP-B (I = idarubicin)M Bertini, R Freilone, B Botto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
Combined modality treatment with a weekly brief chemotherapy (ACOP-B) followed by locoregional radiotherapy in localized-stage intermediate- to high-grade non-Hodgkin's lymphomaR Freilone, B Botto, U Vitolo, et al.
Leukemia|February 16, 2007
Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patientsI Ricca, A Rocci, D Drandi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2006
NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective surveyL Pagano, A Gallamini, G Trapè, et al.
Pageof 7